Navigation Links
After the yeast is gone bacteria continue to develop flavor of sparkling wine

Researchers at the University of Barcelona, Spain, show for the first time that bacteria, in addition to yeast, are involved in the secondary fermentation of the sparkling wine known as Cava. They report their findings today at the 105th General Meeting of the American Society for Microbiology.

"Bacteria found in Cava samples could have a distinctive impact upon sparkling wine quality in terms of aroma, flavor, bubble size and bubble persistence, especially for premium quality wines," says Núria Rius, a researcher on the study.

The traditional Champenoise method of sparkling wine production requires addition of sucrose and yeast strains to the base wine for a second fermentation in the bottle in which the wine is sold. The secondary fermentation produces carbon dioxide which dissolves in the wine and is perceived as bubbles when the bottle is opened, hence the term "sparkling". After the fermentation is completed the Cava wine is aged in the bottles with the yeast for at least nine months, or longer for premium quality wines. During aging, substantial chemical changes take place due to cell lysis which contributes to the sensory characteristics of Cava.

The researchers isolated 617 microbial strains from two Cavas, after 9 to 17 months of bottling. No yeasts were isolated after 10 months of bottling. Gram-negative and Gram-positive bacteria were isolated from both wines. Different phases of the aging process are dominated by different bacteria. Gram-negative bacteria were quickly replaced by Gram-positive bacteria, and after 17 months only Gram-positive bacteria were detected in both sparkling wines.

"The products released by the yeast cells affect wine flavor and serve as nutrients for the growth of bacteria. Although yeasts have the dominating influence on the chemical composition of wine, some changes which influence the sensory quality and consumer acceptability of the wine could be due to growth and lysis of bacteria," says Rius.<
'"/>

Source:American Society for Microbiology


Page: 1 2

Related biology news :

1. Bone Density Recovers After Teens Stop Injected Contraceptive
2. Youth With HIV Take More Risks After New Meds Introduced
3. After a time-shift, mixed signals from the circadian clock
4. Drug Offers Alternative to Surgical Treatment After Miscarriage
5. Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy
6. Researchers Find Drug May Give Some Cardiac Protection 24 Hours After Heart Attack
7. Examination of internal wiring of yeast, worm, and fly reveals conserved circuits
8. Navigating an integrated yeast network
9. GlycoFi announces the first production of antibodies with human glycosylation in yeast
10. From a lowly yeast, researchers divine a clue to human disease
11. GlycoFi and Dartmouth report full humanization of yeast glycosylation pathway in Science
Post Your Comments:
(Date:4/17/2015)... , April 17, 2015 ... concerns, and technological advancement to drive biometric systems ... until 2020   According to a ... Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems market in ... to register growth at CAGR of over 22% ...
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
(Date:4/13/2015)... CHICAGO , April 13, 2015  higi, a ... with ways to more fully engage with their communities ... its industry-leading, privacy protected and secure API.  ... API enables the most accessible, affordable, and convenient vehicle ... The API will ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
... in Uganda who self-paid for their antiretroviral medications experienced ... or supply logistical disruptions. These treatment interruptions led ... patients. , These findings by a team led by ... Kampala, and UCSF are reported in the April 22, ...
... pediatric specialists at Baylor College of Medicine have discovered a ... that allows drugs to enter cancer cells. , The research ... and Biomolecular Chemistry. , All living cells defend themselves ... form a protective cocoon around the cell's inner machinery and ...
... cells to turnover their contents, something that they do ... and radiation, but it is not known if this ... survive the anti-cancer therapy. However, in a study using ... the University of Pennsylvania have now shown that autophagy ...
Cached Biology News:Resistance to anti-HIV drugs in Uganda developed due to drug supply problems 2Buckyballs used as 'passkey' into cancer cells 2
(Date:5/28/2015)... , May 28, 2015  PDS Biotechnology Corp. ... immunotherapy treatment targeting HPV-16, has generated strong T-cell ... Currently, pre-cervical cancer is treated by surgical removal ... and effective non-surgical alternative. Results show that it ... to recognize, target, and kill precancerous and cancerous ...
(Date:5/28/2015)... Biscayne Pharmaceuticals, Inc ., today announced ... hormone-releasing hormone (GHRH) technology will be discussed in a ... The data show that the family of receptors for ... present on many primary breast cancer cells regardless of ... could have broad anti-cancer potential in breast cancer. 1 ...
(Date:5/28/2015)... 28, 2015 CD-adapco, the largest ... software, announced today it is joining the consortium ... provide state-of-the-art engineering simulation tools for analyzing particle ... and experiences in analyzing particle flow that will ... advance the understanding of flow modeling solutions. , ...
(Date:5/28/2015)... Sunnyvale, Californiaa (PRWEB) May 28, 2015 ... on “ The Changing Landscape of EMR/EHR Clinical Data ... Annual Meeting taking place in Washington, DC on June ... the challenges of integrating EMR/EHR systems with EDC, and ... the opportunities brought by eSource and electronic health records/electronic ...
Breaking Biology Technology:PDS Biotechnology reports positive Phase I clinical trial results in proprietary HPV-Cancer Immunotherapy 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 3CD-adapco and PSRI Chartering New Course in Particle Flow Simulations 2Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2
... MA (5/1/2011) High-performance nanotech materials arrayed on a ... efficiency than previous solar thermoelectric generators, opening up solar-thermal ... and industrial uses, a team of researchers from Boston ... Materials . Two technologies have dominated efforts to ...
... April 29, 2011 bioVIGIL, the company that ... announced that Peter Mojica has been named Chief ... visionary technical executive and a research and development ... and social sciences with demonstrated success creating, building ...
... Biopharmaceuticals (Nasdaq: KERX ) today announced the ... of Zerenex ™ (ferric citrate) for the treatment ...  The Zerenex data was presented earlier today at the ... Las Vegas, Nevada, in an oral presentation by David ...
Cached Biology Technology:Solar-thermal flat-panels that generate electric power 2bioVIGIL Names Peter Mojica Chief Technology Officer & CIO 2bioVIGIL Names Peter Mojica Chief Technology Officer & CIO 3Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study 2Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study 3Keryx Biopharmaceuticals Announces Positive Final Data from Zerenex™ Short-Term Phase 3 Study 4
Mouse monoclonal antibody raised against a partial recombinant TPR. NCBI Entrez Gene ID = TPR...
... sufficient materials for 1,464 array sample elements. , , ... , Blocker BSA in PBS (10X): 50 ml , ... Saline: 8 packs , 10% Tween-20: 2 x 10 ... x 25 ml , SuperSignal West Pico Stable Peroxide: ...
... gun system, 100-120 V, is used for ... This handheld device employs an adjustable helium ... biomaterial-coated gold microcarriers from the inner wall ... target cells. This system has a 2 ...
... antibody raised against a partial ... Immunogen: ZFHX4 (NP_078997, 2 ... recombinant protein with GST tag. ... NM_024721 ...
Biology Products: